Angitia Biopharmaceuticals (Series C)

Funding Details
Awarder
Inbox
Date Award
May 30, 2025
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$120,000,000
Company Info
Company Description
Angitia Biopharmaceuticals is a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for serious musculoskeletal diseases.
Market
Musculoskeletal diseases
Location
Woodland Hills, California, USA
Coinvestors
Janus Henderson, OrbiMed, 3H Health Investment, Yonghua Capital, Legend Capital, Elikon Venture
Links
Back to Home Back to Biotechnology Deals View Funding Announcement